Estimates of Survival and Incidence of Cervical Cancer in Loei Province, Thailand, For 2017-2022: Preliminary Results

Authors

  • Kodchamonnakorn Champangoen School of Health Science, Sukhothai Thammathirat Open University, Pakkret, Nonthaburi, Thailand
  • Kodchakorn Thipsanthiah Department of Community Health, Faculty of Public Health, Naresuan University, Phitsanulok, Thailand https://orcid.org/0009-0006-6108-3569
  • Supot Kamsa-ard Department of Epidemiology and Biostatistics, Faculty of Public Health, Khon Kaen University, Khon Kaen, Thailand https://orcid.org/0000-0002-1554-7696
  • Pratap Kumar Jena Department of Public Health, School of Public Health, KIIT Deemed to be University, Bhubaneswar, Odisha, India https://orcid.org/0000-0001-7963-2091

DOI:

https://doi.org/10.55489/njcm.161020255667

Keywords:

Cervical cancer, Survival, Cancer registry

Abstract

Background: Cervical cancer (CC) is a leading cause of cancer-related death among women worldwide, yet regional incidence and survival trends in Thailand are under-documented. This study aimed to estimate the incidence and survival rates of CC in Loei Province, Thailand.

Methodology: This retrospective cohort study analyzed data from 228 CC patients diagnosed between 2017-2022, from the Loei Population-Based Cancer Registry. Survival rates were estimated using the Kaplan-Meier method, while age-standardized incidence rates (ASR) and trends were evaluated using Joinpoint Regression.

Results: The 5-year overall survival rate for CC was 51.1%. The overall age-standardized incidence rate (ASR) was 10.0 per 100,000 person-years. A statistically non-significant decreasing trend was observed during the study period Annual Percent Change (APC) = -0.97%.

Conclusions: The 5-year overall survival for cervical cancer was 51.1%. The decreasing age-standardized incidence rate (ASR) suggests the positive impact of long-standing public health interventions, such as HPV vaccination and screening policies. Continued monitoring of incidence trends and strengthening cancer registry coverage are crucial for enhancing future cancer control programs in Thailand.

References

Global Cancer Observatory. Cancer Today. Lyon, France: IARC; 2023 [Accessed 3 Mar 2025]. Available from: http://gco.iarc.fr/today/home/.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. May 2021;71(3):209-249. DOI: https://doi.org/10.3322/caac.21660 PMid:33538338

WHO;International Agency for Research on Cancer. Cervical cancer. Lyon, France: International Agency for Research on Cancer; 2023 [Accessed 3 Mar 2025]. Available from: https://www.iarc.who.int/cancer-type/cervical-cancer/

Rojanamatin J, Ukranun W, Supaattagorn P, Chiawiriyabunya I, Wongsena M, Chaiwerawattana A, et.al. Cancer in Thailand Vol. X, 2016-2018. Bangkok: Bangkok Medical Publisher; 2021.

Vatanasapt V, Martin N, Sriplung H, et al. Cancer in Thailand Vol. I, 1988-1991. Bangkok: IARC Technical Report No. 16, Lyon, IARC; 1993.

Deerasamee S, Martin N, Sontipong S, et al. Cancer in Thailand Vol. II, 1992-1994. Bangkok: IARC Technical Report No. 34, Lyon: IARC; 1999

Sriplung H, Sontipong S, Martin N, et al. Cancer in Thailand Vol. III, 1995-1997. Bangkok: Bangkok Medical Publisher; 2003.

Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P. Cancer in Thailand Vol. IV, 1998-2000. Bangkok: Bangkok Medical Publisher; 2007.

Khuhaprema T, Srivatanakul P, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y. Cancer in Thailand Vol. V, 2001-2003. Bangkok: Bangkok Medical Publisher; 2010.

Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y, Sangrajrang S. Cancer in Thailand Vol. VI, 2004-2006. Bangkok: Bangkok Medical Publisher; 2012.

Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sangrajrang S. Cancer in Thailand Vol. VII, 2007-2009. Bangkok: Bangkok Medical Publisher; 2013.

Imsamran W, Chaiwerawattana A, Wiangnon S, et al. Cancer in Thailand Vol. VIII, 2010-2012. Bangkok: Bangkok Medical Publisher; 2015

Imsamran W, Pattatang A, Supaattagorn P, Chiawiriyabunya I, Namthaisong K, Wongsena M, et al. Cancer in Thailand Vol. IX 20013-2015. Bangkok: Bangkok Medical Publisher; 2018.

Saenrueang T, Promthet S, Kamsa-Ard S, Pengsaa P. Cervical Cancer in Khon Kaen, Thailand: Analysis of 1990-2014 Incidence Data and Prediction of Future Trends. Asian Pac J Cancer Prev. 2019 Feb 26;20(2):369-375. DOI: https://doi.org/10.31557/APJCP.2019.20.2.369 PMid:30803194 PMCid:PMC6897008

Sriplung H, Singkham P, Iamsirithaworn S, Jiraphongsa C, Bilheem S. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030. Asian Pac J Cancer Prev. 2014;15(22):10003-10008. DOI: https://doi.org/10.7314/APJCP.2014.15.22.10003 PMid:25520060

Pongnikorn D, Daoprasert K, Wongkaew B, Sangkam S, Praditkay M, Meemark R. Trends in Cancer incidence and mortality in northern Thailand, 1993-2017. Lampang: Lampang Cancer Hospital; 2020.

World Health Organization. Cervical Cancer. [Internet], Lyon, France: IARC; 2023 [Accessed 3 Mar 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer/ [Accessed 6 Mar 2025]

Sriamporn S, Khuhaprema T, Parkin M. Cervical cancer screening in Thailand: an overview. J Med Screen. 2006;13 Suppl 1:S39-43. PMID: 17227641.

National Vaccine Institute. Quick Win policy. [Internet], Nonthaburi, Thailand: National Vaccine Institute; 2023 [Accessed 21 Dec 2024]. Available from: https://nvi.go.th/2023/09/20/quick-win/

Champangoen K, Kamsa-ard S, Thipsanthiah K, Srisukhumchai N, Seehawong S, Srimachan S, et al. Incidence of Cervical Cancer Loei Province, 2017-2022. KKU Journal for Public Health Research. 2024;1:1-14.

Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 1st revision. World Health Organization. 2013 [Accessed 20 Jan 2025] Available from: https://iris.who.int/handle/10665/96612.

National Cancer Institute. Thai Cancer Based Program. [Internet], Bangkok Thailand. 2023. [Accessed 8 Nov 2024] Available from:http://tcb.nci.go.th/CWEB/cwebBase.do?Mode=initialApplication.

The Office of the National Economic and Social Development Board. Population Projections for Thailand 2010-2040. Bangkok: The Office of the National Economic and Social Development Board; 2019.

Segi M, editor. Cancer mortality for selected sites in 24 countries (1950-57). In: Age-adjusted death rates for cancer for selected sites (A-classification) in countries. Sendai: Department of Public Health, Tohoku University School of Medicine; 1960.

Doll R. Comparison between registries, age-standardized rates in Waterhouse JAH. In: Muir CS, Correa P, Powell J, editors. Cancer incidence in five continents, Vol III (IARC Scientific Publication No15); 1976; Lyon, FR. International Agency for Research on Cancer; 1976. p.453-459.

StataCorp LLC. Stata: Data Analysis and Statistical Software. StataCorp LLC; 2023 [Accessed 3 Mar 2025]. Available from: http://www.stata.com/.

David G, Kleinbaum Springer. Survival Analysis-A Self-Learning Text. http://www.springer.com/gp/book/9781441966452. [Accessed 18 Mar 2025]

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000 Feb 15;19(3):335-351. DOI: https://doi.org/10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. Erratum in: Stat Med 2001 Feb 28;20(4):655. PMID: 10649300 DOI: https://doi.org/10.1002/sim.811

Khalkhali HR, Gharaaghaji R, Valizadeh R, Kousehlou Z, Ayatollahi H. Ten Years' Survival in Patients with Cervical Cancer and Related Factors in West Azerbaijan Province: Using of Cox Proportion Hazard Model. Asian Pac J Cancer Prev. 2019 May 25;20(5):1345-1351. DOI: https://doi.org/10.31557/APJCP.2019.20.5.1345 PMid:31127888 PMCid:PMC6857867

El Ibrahimi S, Pinheiro PS. The effect of marriage on stage at diagnosis and survival in women with cervical cancer. Psychooncology. 2017;26(5):704-710. DOI: https://doi.org/10.1002/pon.4070 PMid:26810012

Tarney CM, Han J. Postcoital bleeding: a review on etiology, diagnosis, and management. Obstet Gynecol Int. 2014;2014:192087. DOI: https://doi.org/10.1155/2014/192087 PMid:25045355 PMCid:PMC4086375

Chen Q, Zhao J, Xue X, Xie X. Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database. BMC Womens Health. 2024 Jan 28;24(1):75. DOI: https://doi.org/10.1186/s12905-024-02907-5 PMid:38281955 PMCid:PMC10822152

Mebratie AE, Moges NA, Meselu BT, Melesse MF. Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study. PLoS One. 2022 Jun 24;17(6):e0269576. DOI: https://doi.org/10.1371/journal.pone.0269576 PMid:35749539 PMCid:PMC9232151

Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021 May 12;21(1):894. DOI: https://doi.org/10.1186/s12889-021-10907-5 PMid:33975583 PMCid:PMC8114503

National Cancer Institute Thailand. Cancer screening: HPV DNA test. [Internet]. Bangkok, Thailand: National Cancer Institute Thailand; 2023 [Accessed 2 Jan 2025]. Available from: https://nci.go.th/th/screening02.html

Cancer Research UK. Survival for cervical cancer. [Internet], London, UK: Cancer Research UK; 2023 [Accessed 2 Mar 2025]. Available from: https://www.cancerresearchuk.org/about-cancer/cervical-cancer/survival

Deerasamee S, Srivatanakul P, Sriplung H, Nilvachararung S, Tansuwan U, Pitakpraiwan P, Kaewkungwal J, Singhasivanon P, Nimnakorn P, Sankaranarayanan R. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand. Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):547-556. PMID: 18260727.

Health Data Center. Report on cervical cancer screening in women aged 30-60 years, 2020-2023 in Loei province. In : Ministry of Public Health Thailand. 2024.

Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 2021 Nov 11;385(20):1908-1918. DOI: https://doi.org/10.1056/NEJMsr2030640 PMid:34758259 PMCid:PMC12125667

Wang M, Huang K, Wong MCS, Huang J, Jin Y, Zheng ZJ. Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods. J Epidemiol Glob Health. 2024 Mar;14(1):94-101. DOI: https://doi.org/10.1007/s44197-023-00172-7 PMid:38170398 PMCid:PMC11043316

Islami F, Fedewa SA, Jemal A. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States. Prev Med. 2019 Jun;123:316-323. DOI: https://doi.org/10.1016/j.ypmed.2019.04.010 PMid:31002830

Singh M, Jha RP, Shri N, Bhattacharyya K, Patel P, Dhamnetiya D. Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study. BMC Cancer. 2022 Feb 7;22(1):149. DOI: https://doi.org/10.1186/s12885-022-09232-w PMid:35130853 PMCid:PMC8819855

Fappani C, Bianchi S, Panatto D, Petrelli F, Colzani D, Scuri S, et al. HPV type-specific prevalence a decade after the implementation of the vaccination program: results from a pilot study. Vaccines (Basel) 2021 Apr 1;9(4):336. DOI: https://doi.org/10.3390/vaccines9040336 PMid:33916132 PMCid:PMC8066234

Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020 Feb 22;395(10224):575-590. DOI: https://doi.org/10.1016/S0140-6736(20)30068-4 PMid:32007141

Tsu VD, LaMontagne DS, Atuhebwe P, Bloem PN, Ndiaye C. National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects. Prev Med. 2021 Mar;144:106335. DOI: https://doi.org/10.1016/j.ypmed.2020.106335 PMid:33678232 PMCid:PMC7957340

Juntasopeepun P, Davidson PM, Srisomboon J. Issues and challenges in implementing cervical cancer screenings in the emergence of HPV vaccination in Thailand. Collegian. 2012;19(1):45-50. DOI: https://doi.org/10.1016/j.colegn.2011.08.002 PMid:22482282

Department of Disease Control. Vaccine Schedule 2023. [Internet], Nonthaburi, Thailand: Ministry of Public Health; 2023 [Accessed 21 Jan 2025]. Available from: https://ddc.moph.go.th/uploads/ckeditor2/dcd/files/1_Vaccine%20Schedule%202566_V3.pdf

Lewis DR, Chen HS, Cockburn M, Wu XC, Stroup AM, Midthune DN, et al. Preliminary estimates of SEER cancer incidence for 2013. Cancer. 2016 May 15;122(10):1579-1587. DOI: https://doi.org/10.1002/cncr.29953 PMid:26991915

Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011 Jul;39(7 Suppl):42-45. DOI: https://doi.org/10.1177/1403494810393562 PMid:21775350

Downloads

Published

2025-10-01

How to Cite

1.
Champangoen K, Thipsanthiah K, Kamsa-ard S, Jena PK. Estimates of Survival and Incidence of Cervical Cancer in Loei Province, Thailand, For 2017-2022: Preliminary Results. Natl J Community Med [Internet]. 2025 Oct. 1 [cited 2025 Oct. 1];16(10):971-9. Available from: https://njcmindia.com/index.php/file/article/view/5667

Issue

Section

Original Research Articles

Similar Articles

<< < 4 5 6 7 8 9 10 11 12 13 > >> 

You may also start an advanced similarity search for this article.